Cargando…
Immunosenescence and Novel Vaccination Strategies for the Elderly
Vaccination remains the most effective prophylactic intervention for infectious disease in the healthcare professional’s toolkit. However, the efficacy and effectiveness of vaccines decrease with age. This becomes most apparent after an individual reaches 65–70 years old, and results from complex ch...
Autores principales: | Dorrington, Michael G., Bowdish, Dawn M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695377/ https://www.ncbi.nlm.nih.gov/pubmed/23825474 http://dx.doi.org/10.3389/fimmu.2013.00171 |
Ejemplares similares
-
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
por: Pereira, Branca, et al.
Publicado: (2020) -
Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
por: Kennedy, Richard B., et al.
Publicado: (2016) -
Immunosenescence, aging and successful aging
por: Wang, Yunan, et al.
Publicado: (2022) -
Editorial: Immunosenescence after sepsis
por: Lu, Xuan, et al.
Publicado: (2023) -
Editorial: Immunosenescence in the cancer microenvironment
por: Puca, Annibale Alessandro, et al.
Publicado: (2023)